AUTISM SPEAKS
A stranger
AIMS-2-TRIALS: Autism Innovative Medicine Studies 2 Trials
AUTISM SPEAKS INC. NON PROFIT CORPORATION
participó en un
H2020:
H2020-JTI-IMI2-2016-10-two-stage
Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental condition affecting over five million people in the European Union. Th...
2018-06-22 - 2025-05-31 | financed
2018-06-22 - 2025-05-31 | financed
EU-AIMS: European Autism Interventions A Multicentre Study for Developing New Medications
AUTISM SPEAKS INC. NON PROFIT CORPORATION
participó en un
FP7:
Despite dramatic advances in molecular and imaging technologies, there are currently no effective pharmacological treatments for the core sy...
financed
financed
* No data from the current company are not available.